266 related articles for article (PubMed ID: 1828838)
21. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
[TBL] [Abstract][Full Text] [Related]
22. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population.
McDowell GA; Mules EH; Fabacher P; Shapira E; Blitzer MG
Am J Hum Genet; 1992 Nov; 51(5):1071-7. PubMed ID: 1307230
[TBL] [Abstract][Full Text] [Related]
23. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
[TBL] [Abstract][Full Text] [Related]
24. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
[TBL] [Abstract][Full Text] [Related]
25. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.
Bach G; Tomczak J; Risch N; Ekstein J
Am J Med Genet; 2001 Feb; 99(1):70-5. PubMed ID: 11170098
[TBL] [Abstract][Full Text] [Related]
26. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
Navon R; Proia RL
Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
[TBL] [Abstract][Full Text] [Related]
27. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
[TBL] [Abstract][Full Text] [Related]
28. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
[TBL] [Abstract][Full Text] [Related]
29. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
Natowicz MR; Prence EM
Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
[TBL] [Abstract][Full Text] [Related]
30. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
[TBL] [Abstract][Full Text] [Related]
31. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
[TBL] [Abstract][Full Text] [Related]
32. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
33. Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients.
Ribeiro MG; Pinto R; Miranda MC; Suzuki K
Biochim Biophys Acta; 1995 Jan; 1270(1):44-51. PubMed ID: 7827134
[TBL] [Abstract][Full Text] [Related]
34. Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease.
Ohno K; Suzuki K
J Biol Chem; 1988 Dec; 263(34):18563-7. PubMed ID: 2973464
[TBL] [Abstract][Full Text] [Related]
35. Biallelic discrimination assays for the three common Ashkenazi Jewish mutations and a common non-Jewish mutation, in Tay-Sachs disease, using fluorogenic TaqMan probes.
Ward CP; Fensom AH; Green PM
Genet Test; 2000; 4(4):351-8. PubMed ID: 11216658
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
[TBL] [Abstract][Full Text] [Related]
37. Primer system for single cell detection of double mutation for Tay-Sachs disease.
Liu MC; Drury KC; Kipersztok S; Zheng W; Williams RS
J Assist Reprod Genet; 2000 Feb; 17(2):121-6. PubMed ID: 10806593
[TBL] [Abstract][Full Text] [Related]
38. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
39. Identification of an altered splice site in Ashkenazi Tay-Sachs disease.
Arpaia E; Dumbrille-Ross A; Maler T; Neote K; Tropak M; Troxel C; Stirling JL; Pitts JS; Bapat B; Lamhonwah AM
Nature; 1988 May; 333(6168):85-6. PubMed ID: 3362213
[TBL] [Abstract][Full Text] [Related]
40. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
Karpati M; Gazit E; Goldman B; Frisch A; Colombo R; Peleg L
Neurogenetics; 2004 Feb; 5(1):35-40. PubMed ID: 14648242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
